Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients

Published:2017-06-01 Issue:6 Volume:177 Page:774
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Cowley Nicholas J.¹²,Owen Andrew¹³,Shiels Sarah C.³,Millar Joanne³,Woolley Rebecca⁴,Ives Natalie⁴,Osman Husam³,Moss Paul³⁵,Bion Julian F.¹³

Affiliation:

1. Institute of Clinical Sciences, University of Birmingham, Birmingham, England

2. Department of Anaesthesia and Intensive Care, Worcester Royal Hospital, Worcestershire Acute National Health Service Trust, Worcester, England

3. University Hospitals Birmingham National Health Service Foundation Trust, Birmingham, England

4. Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, England

5. Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, England

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus end-organ disease in immunocompromised critically ill patients: key concerns demanding attention;Critical Care;2024-09-10

2. Herpes simplex virus and cytomegalovirus lung reactivations in severe COVID-19 patients: to treat or not to treat? That is (still) the question;Intensive Care Medicine;2024-07-24

3. Pulmonary herpes simplex virus and cytomegalovirus in patients with acute respiratory distress syndrome related to COVID-19;Intensive Care Medicine;2024-07-17

4. The Long-Term Survival of LVAD Patients—A TriNetX Database Analysis;Journal of Clinical Medicine;2024-07-13

5. Critical illness due to infection in people living with HIV;The Lancet HIV;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3